BioNTech SE ADR buy zonthiii
Start price
16.11.20
/
50%
€85.01
Target price
16.11.21
€85.00
Performance (%)
-12.20%
End price
17.11.20
€74.64
Summary
This prediction ended on 17.11.20 with a price of €74.64. The prediction for BioNTech SE ADR disappointed with a performance of -12.20%. zonthiii has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% | - |
iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
According to zonthiii what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Capable Management
Differentiated customer and product portfolio
Growths faster than the competition
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Low dividend yield expected
negative Cash Flow expected
Significant cyclical dependencies
Comments by zonthiii for this prediction
In the thread Biontech SE diskutieren
Buy mit Kursziel 95,0
Kursziel geändert auf 85,0
In the thread Trading Biontech SE
Buy beendet
Stopped prediction by zonthiii for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€76.21
18.11.20
18.11.20
€90.00
18.11.21
18.11.21
274.75%
20.08.21
20.08.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
BioNTech SE ADR
Start price
Target price
Perf. (%)
€74.64
17.11.20
17.11.20
€70.00
17.11.21
17.11.21
2.10%
18.11.20
18.11.20
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group